SUNESIS PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 32223
 
  
 
C07D HETEROCYCLIC COMPOUNDS 24138
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 6119
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1139
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 169
 
  
 
C40B COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES 121
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0158,686 Compounds Useful as Raf Kinase InhibitorsDec 15, 16Jun 08, 17[A61K, C07F, C07D]
2006/0063,795 SNS-595 and methods of using the sameSep 02, 05Mar 23, 06[A61K, C12Q]
2006/0025,437 SNS-595 and methods of using the sameSep 02, 05Feb 02, 06[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920048 Substituted pyrimidines for inhibiting Raf kinase activityDec 15, 16Mar 20, 18[A61K, C07F, C07D]
9873693 Methods of treatment using pyridinonyl PDK1 inhibitorsJul 10, 14Jan 23, 18[A61K, C07D]
9839630 Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acidMar 08, 16Dec 12, 17[A61K, C07D, C07C]
9790229 Bruton's tyrosine kinase inhibitorsJan 25, 16Oct 17, 17[A61K, C07D]
9757363 SNS-595 and methods of using the sameJan 14, 16Sep 12, 17[A61K, C07D]
9724338 Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-OXO-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disordersOct 17, 14Aug 08, 17[A61K, C07D]
9676774 Compounds and compositions for treatment of cancerMay 16, 16Jun 13, 17[C07D]
9556177 Substituted 1,3-thiazoles as synthetic intermediates for preparation of Raf kinase inhibitorsJul 28, 14Jan 31, 17[C07D]
9546165 Heterocyclic compounds useful as PDK1 inhibitorsOct 05, 10Jan 17, 17[C07D]
9469635 Stable SNS-595 compositions and methods of preparationOct 16, 13Oct 18, 16[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0378,505 SNS-595 AND METHODS OF USING THE SAMEAbandonedFeb 03, 14Dec 25, 14[A61K]
2014/0205,679 METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID IN COMBINATION THERAPYAbandonedAug 21, 13Jul 24, 14[A61K]
2014/0205,680 METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF CANCERAbandonedOct 17, 13Jul 24, 14[A61K]
2013/0102,559 METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF ANTECEDENT HEMATOLOGIC DISORDERSAbandonedMay 22, 12Apr 25, 13[A61K, C07D]
2012/0148,564 METHODS OF USING SNS-595 FOR TREATMENT OF CANCER SUBJECTS WITH REDUCED BRCA2 ACTIVITYAbandonedMar 01, 10Jun 14, 12[A61K, C12Q, C12N, A61P]
2012/0077,711 Novel Ligands and Libraries of LigandsAbandonedMay 26, 11Mar 29, 12[C07D, C07C, G01N, C40B]
2012/0040,951 HETEROARYL COMPOUNDS USEFUL AS RAF KINASE INHIBITORSAbandonedDec 30, 09Feb 16, 12[A61K, C07D, C12N, A61P]
2011/0293,745 AURORA KINASE INHIBITORSAbandonedMar 16, 09Dec 01, 11[A61K, C07D, A61P]
2011/0263,524 SNS-595 AND METHODS OF USING THE SAMEAbandonedApr 27, 11Oct 27, 11[A61K, A61P]
7968536 Heterocyclic compounds useful as RAF kinase inhibitorsExpiredJun 30, 08Jun 28, 11[A61K, C07D]
7932257 Substituted pyrazolo[4,3-d]pyrimidines as aurora kinase inhibitorsExpiredJul 21, 06Apr 26, 11[A61K, C07D, A61P]
2011/0059,976 PYRIDO PYRIMIDINONES, DIHYDRO PYRIMIDO PYRIMIDINONES AND PTERIDINONES USEFUL AS RAF KINASE INHIBITORSAbandonedJul 26, 10Mar 10, 11[A61K, C07D, C12N, A61P]
2011/0008,371 METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF ANTECEDENT HEMATOLOGIC DISORDERSAbandonedDec 10, 08Jan 13, 11[A61K, A61P]
2010/0298,342 Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's DiseaseAbandonedSep 04, 07Nov 25, 10[A61K, C07D, A61P]
7767687 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitorsExpiredDec 12, 05Aug 03, 10[A61K, C07D]
2010/0179,123 THIENOPYRIMIDINES USEFUL AS AURORA KINASE INHIBITORSAbandonedOct 08, 09Jul 15, 10[A61K, C07D, C12N, A61P]
2010/0048,609 PHARMACEUTICAL DOSAGE FORMS FOR (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACIDAbandonedAug 01, 07Feb 25, 10[A61K, A61P]
2010/0022,399 METHODS FOR RAPIDLY IDENTIFYING SMALL ORGANIC MOLECULE LIGANDS FOR BINDING TO BIOLOGICAL TARGET MOLECULESAbandonedOct 01, 09Jan 28, 10[C40B]
7601725 Thienopyrimidines useful as Aurora kinase inhibitorsExpiredJul 15, 05Oct 13, 09[A61K, A01N, C07D]
2009/0118,274 MONOCYCLIC AMINOPROPYL TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN SAbandonedFeb 14, 08May 07, 09[A61K, C07D, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.